Shanghai Junshi Biosciences Co., Ltd. (688180.SS)
CNY 30.2
(0.77%)
CNY 30.2
(0.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.89 Billion | -1.77 Billion | -641.9 Million | -1.49 Billion | -1.18 Billion | -510.75 Million |
| Net Income | -2.28 Billion | -2.67 Billion | -592.64 Million | -1.66 Billion | -763.12 Million | -717.56 Million |
| Depreciation & Amortization | 332.52 Million | 293.65 Million | 262.55 Million | 151.36 Million | 59.59 Million | 30.2 Million |
| Deferred income taxes | 125.03 Million | -139.87 Million | -173.81 Million | -5.68 Million | 8.71 Million | 17.16 Million |
| Stock-based compensation | 22.98 Million | 91.91 Million | 192.75 Million | 30.72 Million | 11.79 Million | 21.7 Million |
| Change in working capital | -65.18 Million | 687.18 Million | -318.77 Million | -13.06 Million | -464.06 Million | 126.68 Million |
| Other non-cash items | 741.16 Million | -32.99 Million | -11.97 Million | 7.31 Million | -39.94 Million | 11.05 Million |
| Investing Cash Flow | -1.03 Billion | -467.61 Million | -1.88 Billion | -697.97 Million | -952.03 Million | -420.98 Million |
| Investments in PPE | -832.57 Million | -393.95 Million | -886.22 Million | -592.68 Million | -863.14 Million | -557.37 Million |
| Acquisitions | 7.09 Million | -93.78 Million | -440.08 Million | 2.9 Million | -73.74 Million | 1.25 Million |
| Investment purchases | -1.45 Billion | -8.48 Million | -1.16 Billion | -245.16 Million | -117.34 Million | -403.5 Million |
| Sales/Maturities of investments | 1.24 Billion | 91 Million | 565.28 Million | 70.13 Million | 72.2 Million | 513.77 Million |
| Other Investing Activities | 1.57 Million | -62.4 Million | 49.69 Million | 66.83 Million | 30.01 Million | 24.86 Million |
| Financing Cash Flow | 708.82 Million | 4.64 Billion | 2.66 Billion | 4.41 Billion | 593.58 Million | 3.43 Billion |
| Debt repayment | -496.18 Million | -113.44 Million | -793.33 Million | -52.52 Million | -1.38 Billion | -106 Million |
| Dividends payments | -38.22 Million | -19.15 Million | -16.69 Million | -43.15 Million | -58.59 Million | - |
| Common Stock Repurchased | -26.89 Million | 19.15 Million | 16.69 Million | - | 58.59 Million | - |
| Common Stock Issuance | -26.89 Million | 3.81 Billion | 2.15 Billion | 4.84 Billion | 403.83 Million | 3.01 Billion |
| Other Financing Activities | 292.4 Million | 944.19 Million | 1.3 Billion | 4.5 Billion | 1.57 Billion | 525.7 Million |
| Accounts receivables | -314.41 Million | 1.22 Billion | -770.55 Million | -482.17 Million | -410.44 Million | -51.92 Million |
| Accounts payables | 262.67 Million | -505.72 Million | 702.32 Million | 685.96 Million | 86.02 Million | 189.89 Million |
| Inventory | -32.44 Million | -136.39 Million | -154.82 Million | -166.98 Million | -132.19 Million | -18.96 Million |
| Other working capital | 19 Million | 99.56 Million | -95.71 Million | -49.87 Million | -7.44 Million | 145.64 Million |
| Cash at beginning of period | 6.03 Billion | 3.5 Billion | 3.38 Billion | 1.21 Billion | 2.76 Billion | 266.29 Million |
| Cash at end of period | 3.78 Billion | 5.99 Billion | 3.5 Billion | 3.38 Billion | 1.21 Billion | 2.76 Billion |
| Capital Expenditure | -832.57 Million | -393.95 Million | -886.22 Million | -592.68 Million | -863.14 Million | -557.37 Million |
| Effect of forex changes on cash | 7.55 Million | 92.26 Million | -23.22 Million | -45.76 Million | -4.06 Million | -3.59 Million |
| Net cash flow / Change in cash | -2.24 Billion | 2.49 Billion | 119.6 Million | 2.17 Billion | -1.54 Billion | 2.49 Billion |
| Free Cash Flow | -2.73 Billion | -2.16 Billion | -1.52 Billion | -2.09 Billion | -2.05 Billion | -1.06 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -281.81 Million | -361.92 Million | -283.02 Million | -876.61 Million | -2.28 Billion | -409.4 Million |
| Depreciation & Amortization | - | 165.19 Million | 82.59 Million | 87.32 Million | 332.52 Million | 87.32 Million |
| Deferred income taxes | - | - | - | 129.23 Million | 125.03 Million | -341.89 Million |
| Stock-based compensation | - | - | - | 23.97 Million | 22.98 Million | -17.14 Million |
| Change in working capital | - | 53.38 Million | - | -327.85 Million | -65.18 Million | 359.04 Million |
| Other non-cash items | 13.15 Million | -345.42 Million | -93.54 Million | 724.68 Million | 741.16 Million | -113.85 Million |
| Investing Cash Flow | -114.49 Million | -867.67 Million | -73.27 Million | -380.97 Million | -1.03 Billion | -493.61 Million |
| Investments in PPE | -225.04 Million | -183.42 Million | -212.29 Million | -227.91 Million | -832.57 Million | -403.23 Million |
| Acquisitions | - | 1.86 Million | - | 4.07 Million | 7.09 Million | -62.36 Million |
| Investment purchases | -574 Million | -739.93 Million | -25.06 Million | -118.99 Million | -1.45 Billion | -110 Million |
| Sales/Maturities of investments | 651.37 Million | -49.61 Million | 150 Million | 41.46 Million | 1.24 Billion | 6.79 Million |
| Other Investing Activities | 33.17 Million | -10.45 Million | 14.08 Million | -79.59 Million | 1.57 Million | 75.19 Million |
| Financing Cash Flow | 157.64 Million | -481.08 Million | 1.21 Billion | 270.63 Million | 708.82 Million | 221.07 Million |
| Debt repayment | -184.77 Million | -447.39 Million | -1.24 Billion | -282.72 Million | -496.18 Million | -272.55 Million |
| Dividends payments | - | -20.22 Million | -13.64 Million | -10.52 Million | -38.22 Million | -9.69 Million |
| Common Stock Repurchased | - | -4 Million | - | -26.89 Million | -26.89 Million | - |
| Common Stock Issuance | 4 Million | -4 Million | - | -26.89 Million | -26.89 Million | - |
| Other Financing Activities | -31.13 Million | 18.05 Million | -28.06 Million | 67.66 Million | 292.4 Million | 493.63 Million |
| Accounts receivables | - | 73.73 Million | - | -314.41 Million | -314.41 Million | 287.26 Million |
| Accounts payables | - | - | - | - | 262.67 Million | - |
| Inventory | - | -24.93 Million | - | -32.44 Million | -32.44 Million | 89.86 Million |
| Other working capital | - | 4.58 Million | - | 19 Million | 19 Million | -18.08 Million |
| Cash at beginning of period | 2.71 Billion | 4.54 Billion | 3.78 Billion | 4.16 Billion | 6.03 Billion | 4.85 Billion |
| Cash at end of period | 2.47 Billion | 2.71 Billion | 4.55 Billion | 3.78 Billion | 3.78 Billion | 4.14 Billion |
| Capital Expenditure | -225.04 Million | -183.42 Million | -212.29 Million | -227.91 Million | -832.57 Million | -403.23 Million |
| Effect of forex changes on cash | - | 3.52 Million | 1.24 Million | -13.98 Million | 7.55 Million | -3.56 Million |
| Net cash flow / Change in cash | -237.13 Million | -1.83 Billion | 771.11 Million | -380.83 Million | -2.24 Billion | -712.04 Million |
| Free Cash Flow | -493.7 Million | -672.19 Million | -588.86 Million | -467.16 Million | -2.73 Billion | -839.17 Million |
IPSEF
8455
LOM
0535
SIMPLEXINF
6592